Hematopoiesis-related microRNA expression in myelodysplastic syndromes. - Wikidata - awgldk - TriplyDB

Hematopoiesis-related microRNA expression in myelodysplastic syndromes.

Hematopoiesis-related microRNA expression in myelodysplastic syndromes.

http://www.wikidata.org/entity/Q54456418

about

The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases Dissecting microRNA-mediated regulation of stemness, reprogramming, and pluripotency Benzene-Induced Aberrant miRNA Expression Profile in Hematopoietic Progenitor Cells in C57BL/6 Mice Hematopoietic stem cells and retroviral infection.Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements.miRNA expression profiles in myelodysplastic syndromes reveal Epstein-Barr virus miR-BART13 dysregulation.Prognostic role of microRNA-181a/b in hematological malignancies: a meta-analysis Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome Serum microRNA-21 as a potential biomarker for response to hypomethylating agents in myelodysplastic syndromes Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication.Overexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-κB activation and enhances erythroid differentiation arrest miR-590-5p, miR-219-5p, miR-15b and miR-628-5p are commonly regulated by IL-3, GM-CSF and G-CSF in acute myeloid leukemia.Transfer RNA detection by small RNA deep sequencing and disease association with myelodysplastic syndromes.Circulating microRNAs let-7a and miR-16 predict progression-free survival and overall survival in patients with myelodysplastic syndrome.SLC7A5 act as a potential leukemic transformation target gene in myelodysplastic syndrome.Microvesicles from Mesenchymal Stromal Cells Are Involved in HPC-Microenvironment Crosstalk in Myelodysplastic Patients.miR-181a Targets RGS16 to Promote Chondrosarcoma Growth, Angiogenesis, and Metastasis.Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression.TGF-β upregulates miR-181a expression to promote breast cancer metastasis.MiR-487a Promotes TGF-β1-induced EMT, the Migration and Invasion of Breast Cancer Cells by Directly Targeting MAGI2.Transcriptional regulation of miR-10a/b by TWIST-1 in myelodysplastic syndromes.Deregulation of microRNAs in myelodysplastic syndrome.MicroRNA-181a - a tale of discrepancies.Implication of microRNAs in the pathogenesis of MDS.Myelodysplastic syndrome hematopoietic stem cell.The genetic basis of phenotypic heterogeneity in myelodysplastic syndromes.Molecular mechanism of microRNA involvement in genesis of myelodysplastic syndrome and its transformation to acute myeloid leukemia.Epigenetic alterations and microRNAs: new players in the pathogenesis of myelodysplastic syndromes.The Interplay between PP2A and microRNAs in Leukemia.MicroRNAs in Myeloid Hematological Malignancies.The role of microRNA in myelodysplastic syndromes: beyond DNA methylation and histone modification.Deregulated microRNA expression and its pathogenetic implications for myelodysplastic syndromes.MicroRNAs as prognostic biomarker and relapse indicator in leukemia.Loss of SHIP-1 protein expression in high-risk myelodysplastic syndromes is associated with miR-210 and miR-155.MicroRNA expression in tumor cells from Waldenstrom's macroglobulinemia reflects both their normal and malignant cell counterparts.Epigenetic silencing of the oncogenic miR-17-92 cluster during PU.1-directed macrophage differentiation.MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.Differential expression of microRNAs in CD34+ cells of 5q- syndrome.Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies Biological activity of lenalidomide in myelodysplastic syndromes with del5q: results of gene expression profiling from a multicenter phase II study.

P2860

Q24608620-A22CBB98-2E65-4E47-8AF1-B67326FD2043 Q26752448-60323166-98D0-41A7-A214-2425E1383158 Q28394910-963B2665-81F4-44E7-8B79-12109312E72C Q33677922-42D9C145-E0CD-4ADF-8072-439DD7677BF6 Q33919931-7A6058B4-25A8-4A8D-81CF-4D7AA0787BA2 Q34190472-C911B2A0-3C9A-4E56-906D-6B796450D329 Q34637868-86354288-623E-4D84-8935-F54ED350D210 Q34705185-EB4855D3-315D-4449-9725-92D3DA8AF6D0 Q35087659-CBBF9AD5-121C-43A9-9076-A111A7679D2D Q35125641-459C5759-47A9-4C19-8D57-EBE54EB3DA67 Q35137424-B2C94FC5-81FB-4E45-92A5-6DB514EAEA18 Q35690892-13683CA7-5550-4CED-8868-1A86E5AD591C Q35785942-208F9CE0-02AF-4D6B-ACA8-A169CBBC4081 Q35802426-766AB3E1-FB21-4EDC-9EEF-531D5B40A08B Q35866423-E097E9EE-1457-4689-AFC4-D502ECE14C1E Q35911998-70283753-D8E3-4D3F-A514-79C6067BFA7B Q36068725-8BF58786-1346-4E0E-A4E4-FE9A43B24113 Q36240614-23A20514-97E0-45BE-8446-DFA4F14984A2 Q36497263-C1217092-FA24-4630-A2D8-0729EF4C39CC Q36727102-B57A8B2B-5977-4834-8EBA-D56DEC8E9270 Q36862388-A3D3B323-9D37-4F80-A85E-23AF1521A2F2 Q37919716-62EA5B04-1038-4214-92DD-3BD415B1EA3B Q37986129-3E784BD7-B610-4B39-B32F-5B7369259F59 Q38008748-F3F166D2-163B-4DF7-B0F7-C7C14E6D4C3F Q38050694-AA42B126-23E5-471B-AB76-BB3B1C88B74D Q38061848-1A5E0AD3-1276-4133-94D5-7C64C4AA52D9 Q38074249-A7BC9397-E052-4E4F-892F-0A4E10E5F33F Q38113961-F70A8356-B31A-49A4-8F0B-E3A83DCF3463 Q38370368-C70A7D86-8698-4049-9349-16DFDA6DD9AE Q38599595-662B2CDA-ACF1-49D8-9BDB-12DB2BB98356 Q38698438-602EAE9B-E186-4754-8098-C5552EA1D624 Q38880958-9FDC4F09-B715-4016-877F-88109CA54519 Q39167466-BC62294B-78A5-4AED-917C-A61E915BF448 Q39411436-48C3209E-8DE8-435D-AB81-1D9B00CECECF Q39580400-FE99A18D-5848-404D-A1AE-36EA228610E6 Q39592066-E4F3899D-F7CB-4667-9892-29F3EF996DFD Q41760459-6D031D60-00BE-4B49-9D1A-AD64FEA920CA Q41863741-A16B6A07-64B8-42AB-9933-0CBEED4EB81E Q42421291-AA705C94-48B0-431B-963A-BB249E1ACBB7 Q44850006-FA6F217E-8149-4CC6-B362-CB8F5A801AD3

P2860

Hematopoiesis-related microRNA expression in myelodysplastic syndromes.

http://www.wikidata.org/entity/Q54456418

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Hematopoiesis-related microRNA expression in myelodysplastic syndromes.

@en

Hematopoiesis-related microRNA expression in myelodysplastic syndromes.

@nl

type

label

Hematopoiesis-related microRNA expression in myelodysplastic syndromes.

@en

Hematopoiesis-related microRNA expression in myelodysplastic syndromes.

@nl

prefLabel

Hematopoiesis-related microRNA expression in myelodysplastic syndromes.

@en

Hematopoiesis-related microRNA expression in myelodysplastic syndromes.

@nl

P1433

Q54456418-674F07D7-0DD0-4AF6-8747-C6EA53C0B4D2

P1476

Q54456418-63A0CA8C-F7F5-4BE7-B973-F454A0604FBB

P2093

Q54456418-44857CE6-FD57-4698-8D0D-6B5BF6048630

Q54456418-4DD6A2C4-AE64-4AC9-9F3B-768544BE2091

Q54456418-6D6ED879-78B5-4361-BF6A-3AC96970839D

Q54456418-808996CA-4416-4B25-8A53-D8DB1ADBACD3

Q54456418-9868E55F-06F0-47F4-8326-B01289963DE5

Q54456418-B4928539-9674-4373-945D-66DFD98C94C8

Q54456418-CED00A70-79AC-44DB-8DEC-D433445178E0

P2860

Q54456418-0082D963-A7EA-4E41-AD39-6B38F8FFB10D

Q54456418-02A16F27-656D-4875-A881-6434C3DAB67E

Q54456418-131F836A-94ED-407C-9168-01C469A8DCF1

Q54456418-3A6EFAE8-364A-4C45-9C72-228415137F1A

Q54456418-59D73AE6-8E09-4342-B22D-2BE1ED96C255

Q54456418-62190774-FB67-4DEE-9B27-0DEC44DADD86

Q54456418-64B0240A-6A6C-407F-9B67-3AE54BD424F5

Q54456418-6AD1F9B0-A102-490B-B8C9-C12B02708C59

Q54456418-7383696C-4CCC-48F8-AED2-BB1AB9DFE591

Q54456418-7C7033BB-39C3-45D3-90D8-52D84CBD9EF6

P304

Q54456418-001203C7-46BD-4389-8033-89CA6D76DA20

P31

Q54456418-3DC5901E-5125-4415-9D80-CEC1FFAA7F04

P356

Q54456418-1DE8A550-8D0C-4F4F-9E86-BB513CF8E67A

P433

Q54456418-96DD46CA-FCD6-457F-8919-7430416C8380

P478

Q54456418-1A457B7A-EB68-48FB-BA05-6BFCE0D61095

P50

Q54456418-86C00F00-C6C9-4B7C-B2B8-C51A70FADA98

Q54456418-8D928BBD-962A-4F6A-8B8F-B9DD6D3E94F0

Q54456418-B0AF0358-FF86-493B-9645-D28B5484ABC0

Q54456418-BAF3F960-CBEB-45E3-A901-06B48E132D9E

P577

Q54456418-BF11F43E-7D6C-4DB7-BB2B-AC3538B9E866

P698

Q54456418-06BD389F-8BFB-453A-ABFF-32434C4DBDF4

P921

Q54456418-40E093DB-CEA5-4026-9C91-C359F17BDBBB

Q54456418-76360202-9AD5-493E-92F5-EFF4CF7D6281

P356

10428190903147645

P1433

Leukemia & Lymphoma

P1476

Hematopoiesis-related microRNA expression in myelodysplastic syndromes.

@en

P2093

Aina Pons

http://www.w3.org/2001/XMLSchema#string

Anna Gaya

http://www.w3.org/2001/XMLSchema#string

Benet Nomdedeu

http://www.w3.org/2001/XMLSchema#string

Emili Montserrat

http://www.w3.org/2001/XMLSchema#string

Mohamed Belkaid

http://www.w3.org/2001/XMLSchema#string

Sandra Valera

http://www.w3.org/2001/XMLSchema#string

Tania Diaz

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA fingerprints during human megakaryocytopoiesis

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype

NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control

MicroRNA profiling of the murine hematopoietic system.

MicroRNAs modulate hematopoietic lineage differentiation

A microRNA polycistron as a potential human oncogene

Oncomirs - microRNAs with a role in cancer

Identification of novel genes coding for small expressed RNAs

P304

1854-1859

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428190903147645

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19883312

http://www.w3.org/2001/XMLSchema#string

P921

microRNA expression